America prides itself as a leader in technological innovation and medical research. Home to some of the largest and well respected cancer centers in the world, the U.S. has stood as the epicenter for cancer research for several decades. If the U.S. wishes to retain...
Government, academia, pharmaceutical and diagnostic companies are collaborating to create the National Cancer Institute’s Blood Profiling Atlas – an open access liquid biopsy database. The database pulls together scientific data for use by researchers in an effort to...
The Blue Ribbon Panel’s report, presented to the National Cancer Advisory Board on September 7th, describes 10 recommendations for the Cancer Moonshot goal of accelerating cancer research. Cancer Moonshot’s goal of 10 years of progress in 5 is bringing diverse...
Sy Mukherjee, BioPharmaDive posted an article on PharmaVoice about Cancer Moonshot 2020 – a national effort to find the cure for cancer headed up by Vice President Joe Biden. Mukherjee explains that the National Immunotherapy Coalition (NIC) made up of large pharma,...
According to a recent article by Senator Amy Klobuchar, the United States has always been the world leader when it comes to biomedical research and innovation. However, many other countries are starting to rapidly catch up, and the United States may need to put more...
Stan Collender, a cancer patient, shares an interesting New York Times op ed piece on why so few cancer patients participate in clinical trials. Stan is a diagnosed with Merkel cell carcinoma (a rare skin cancer) and is enrolled in a clinical trial with, in his...
